Barlow Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Barlow Wealth Partners's LLY Position: Q3 2026 in Review
Barlow Wealth Partners increased its Eli Lilly (LLY) stake by 79% in Q3 2026, buying an estimated $1.36M and bringing the position to 2,599 shares worth $3.01M. The position accounts for 0.31% of the portfolio, ranked #36.
Barlow Wealth Partners first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $18.9M in Q1 2025. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Barlow Wealth Partners held 2,599 shares of Eli Lilly worth $3.01M as of Q3 2026.
- Barlow Wealth Partners bought 1,151 Eli Lilly shares in Q3 2026, an estimated $1.36M.
- Eli Lilly made up 0.31% of Barlow Wealth Partners's portfolio in Q3 2026, its #36 holding.
- Barlow Wealth Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- Barlow Wealth Partners's Eli Lilly position peaked at $18.9M in Q1 2025.
- 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Barlow Wealth Partners's 13F filing for Q3 2026, filed 15 Oct 2026.